UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

JNCI : Journal of the National Cancer Institute, 2009-05, Vol.101 (9), p.644-650

2009

Volltextzugriff (PDF)

Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)

Annals of oncology, 2013-08, Vol.24 (8), p.1986-1993

2013

Volltextzugriff (PDF)

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

Advanced drug delivery reviews, 2005-01, Vol.57 (3), p.411-430

2005

Volltextzugriff (PDF)

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

Annals of oncology, 2017-07, Vol.28 (7), p.1560-1568

2017

Volltextzugriff (PDF)

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.143-151

2013

Volltextzugriff (PDF)

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Annals of oncology, 2012-06, Vol.23 (6), p.1607-1616

2012

Volltextzugriff (PDF)

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200

Annals of oncology, 2015-05, Vol.26 (5), p.973-981

2015

Volltextzugriff (PDF)

HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

The New England journal of medicine, 2006-05, Vol.354 (20), p.2103-2111

2006

Volltextzugriff (PDF)

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)

Annals of oncology, 2010-02, Vol.21 (2), p.283-290

2010

Volltextzugriff (PDF)

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.401-409

2011

Volltextzugriff (PDF)

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

European journal of cancer (1990), 2001-06, Vol.37 (9), p.1096-1103

2001

Volltextzugriff (PDF)

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

Vaccine, 2001-09, Vol.19 (32), p.4732-4742

2001

Volltextzugriff (PDF)

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

Investigational new drugs, 2006-09, Vol.24 (5), p.435-439

2006

Volltextzugriff (PDF)

Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1235-1237

Bramwell, V H

2001

Volltextzugriff (PDF)

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

The Lancet (British edition), 1997-09, Vol.350 (9082), p.911-917

1997

Volltextzugriff (PDF)

The rational design of vaccines

Drug discovery today, 2005-11, Vol.10 (22), p.1527-1534

2005

Volltextzugriff (PDF)

Adjuvant synergy: The effects of nasal coadministration of adjuvants

Immunology and cell biology, 2004-12, Vol.82 (6), p.628-637

2004

Volltextzugriff (PDF)

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

The Lancet (British edition), 1994-04, Vol.343 (8902), p.886-889

1994

Volltextzugriff (PDF)

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in Premenopausal women with node-positive breast cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2651-2658

1998

Volltextzugriff (PDF)

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

European journal of cancer (1990), 2005, Vol.41 (2), p.225-230

2005

Volltextzugriff (PDF)

Stimulation of spleen cells in vitro by nanospheric particles containing antigen

Journal of controlled release, 2003-01, Vol.86 (1), p.25-32

2003

Volltextzugriff (PDF)

Particulate delivery systems for biodefense subunit vaccines

Advanced drug delivery reviews, 2005-06, Vol.57 (9), p.1247-1265

2005

Volltextzugriff (PDF)

The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma

Seminars in oncology, 1997-10, Vol.24 (5), p.561-571

Bramwell, V H

1997

Volltextzugriff (PDF)

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1137-1149

1994

Volltextzugriff (PDF)

Do authors of review articles use systematic methods to identify, assess and synthesize information?

Annals of oncology, 1997-12, Vol.8 (12), p.1185-1195

1997

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(183)

Publikationsform

Artikel
(216)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(134)
Science & Technology
(123)
Life Sciences & Biomedicine
(117)
Female
(92)
Biological And Medical Sciences
(71)
Oncology
(71)
Adult
(69)
Middle Aged
(66)
Medical Sciences
(65)
Male
(50)
Pharmacology. Drug Treatments
(46)
Chemotherapy
(44)
Sarcoma - Drug Therapy
(41)
Aged
(40)
Antineoplastic Agents
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(36)
Adolescent
(31)
Soft Tissue Neoplasms - Drug Therapy
(31)
Breast Neoplasms - Drug Therapy
(25)
Drug Evaluation
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200

HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

The rational design of vaccines

Adjuvant synergy: The effects of nasal coadministration of adjuvants

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in Premenopausal women with node-positive breast cancer

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

Stimulation of spleen cells in vitro by nanospheric particles containing antigen

Particulate delivery systems for biodefense subunit vaccines

The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Do authors of review articles use systematic methods to identify, assess and synthesize information?

Suchergebnisse filtern